Your browser doesn't support javascript.
loading
YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury.
Planas-Paz, Lara; Sun, Tianliang; Pikiolek, Monika; Cochran, Nadire R; Bergling, Sebastian; Orsini, Vanessa; Yang, Zinger; Sigoillot, Frederic; Jetzer, Jasna; Syed, Maryam; Neri, Marilisa; Schuierer, Sven; Morelli, Lapo; Hoppe, Philipp S; Schwarzer, Wibke; Cobos, Carlos M; Alford, John L; Zhang, Le; Cuttat, Rachel; Waldt, Annick; Carballido-Perrig, Nicole; Nigsch, Florian; Kinzel, Bernd; Nicholson, Thomas B; Yang, Yi; Mao, Xiaohong; Terracciano, Luigi M; Russ, Carsten; Reece-Hoyes, John S; Gubser Keller, Caroline; Sailer, Andreas W; Bouwmeester, Tewis; Greenbaum, Linda E; Lugus, Jesse J; Cong, Feng; McAllister, Gregory; Hoffman, Gregory R; Roma, Guglielmo; Tchorz, Jan S.
Affiliation
  • Planas-Paz L; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Sun T; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Pikiolek M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Cochran NR; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Bergling S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Orsini V; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Yang Z; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Sigoillot F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Jetzer J; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Syed M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Neri M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Schuierer S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Morelli L; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Hoppe PS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Schwarzer W; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Cobos CM; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland; Hospital Aleman, Buenos Aires, Argentina.
  • Alford JL; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Zhang L; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Cuttat R; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Waldt A; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Carballido-Perrig N; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Nigsch F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Kinzel B; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Nicholson TB; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Yang Y; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Mao X; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Terracciano LM; Institute for Pathology, University Hospital Basel, Basel, Switzerland.
  • Russ C; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Reece-Hoyes JS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Gubser Keller C; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Sailer AW; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Bouwmeester T; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Greenbaum LE; Novartis Institutes for Biomedical Research, Novartis Pharma AG, East Hanover, NJ, USA.
  • Lugus JJ; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Cong F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • McAllister G; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Hoffman GR; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Cambridge, MA, USA.
  • Roma G; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Tchorz JS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: jan.tchorz@novartis.com.
Cell Stem Cell ; 25(1): 39-53.e10, 2019 07 03.
Article in En | MEDLINE | ID: mdl-31080135
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Ducts / Cell Cycle Proteins / Adaptor Proteins, Signal Transducing / Epithelial Cells / Acute Lung Injury / Induced Pluripotent Stem Cells Limits: Animals / Humans / Male Language: En Journal: Cell Stem Cell Year: 2019 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Ducts / Cell Cycle Proteins / Adaptor Proteins, Signal Transducing / Epithelial Cells / Acute Lung Injury / Induced Pluripotent Stem Cells Limits: Animals / Humans / Male Language: En Journal: Cell Stem Cell Year: 2019 Type: Article Affiliation country: Switzerland